| Q37445355 | A case of tuberculous arthritis following the use of etanercept |
| Q91324793 | A review of computational and mathematical modeling contributions to our understanding of Mycobacterium tuberculosis within-host infection and treatment |
| Q34784800 | A role for tumour necrosis factor-alpha, complement C5 and interleukin-6 in the initiation and development of the mycobacterial cord factor trehalose 6,6'-dimycolate induced granulomatous response |
| Q49508046 | Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 2: management |
| Q33627062 | Association of reduced tumor necrosis factor alpha, gamma interferon, and interleukin-1beta (IL-1beta) but increased IL-10 expression with improved chest radiography in patients with pulmonary tuberculosis |
| Q35188484 | BCG vaccination induces different cytokine profiles following infant BCG vaccination in the UK and Malawi |
| Q95362569 | Cell death at the cross roads of host-pathogen interaction in Mycobacterium tuberculosis infection |
| Q99635744 | Chest roentgenography is complementary to interferon-gamma release assay in latent tuberculosis infection screening of rheumatic patients |
| Q43628272 | Comparative Genomics of Sibling Species of Fonsecaea Associated with Human Chromoblastomycosis |
| Q39158040 | Complex cytokine profiles induced by BCG vaccination in UK infants |
| Q90393140 | Concordance between tuberculin skin test and interferon-gamma release assay for latent tuberculosis screening in inflammatory bowel disease |
| Q42576505 | Contrasting roles of SPARC-related granuloma in bacterial containment and in the induction of anti-Salmonella typhimurium immunity |
| Q53062262 | Correlation between lymph node pathology and chemokine expression during bovine tuberculosis. |
| Q38986062 | Cytokines and Chemokines in Mycobacterium tuberculosis Infection |
| Q91057942 | Dynamic balance of pro- and anti-inflammatory signals controls disease and limits pathology |
| Q37112790 | Endocytosis of Mycobacterium tuberculosis heat shock protein 60 is required to induce interleukin-10 production in macrophages |
| Q34113978 | Etanercept exacerbates inflammation and pathology in a rabbit model of active pulmonary tuberculosis |
| Q79224117 | Expression and function of the purinergic receptor P2X7 in patients with pulmonary tuberculosis |
| Q28255669 | Foamy macrophages and the progression of the human tuberculosis granuloma |
| Q42278175 | Functional profile of CD4+ and CD8+ T cells in latently infected individuals and patients with active TB. |
| Q82448054 | Genetic architecture of tuberculosis resistance in a mouse model of infection |
| Q34105808 | Genome-wide transcriptional profiling of peripheral blood leukocytes from cattle infected with Mycobacterium bovis reveals suppression of host immune genes |
| Q37969755 | Granuloma transplantation: an approach to study mycobacterium-host interactions |
| Q41961805 | Granuloma with langhans giant cells: An overview |
| Q28076037 | Granulomas and Inflammation: Host-Directed Therapies for Tuberculosis |
| Q36919069 | Half-truths and selective memory: Interferon gamma, CD4(+) T cells and protective memory against tuberculosis. |
| Q35860042 | Herpes simplex encephalitis during treatment with tumor necrosis factor-alpha inhibitors |
| Q35865474 | High-throughput transcriptomics reveals common and strain-specific responses of human macrophages to infection with Mycobacterium abscessus Smooth and Rough variants |
| Q40202836 | Histological characteristics of the abdominal aortic wall in patients with vascular chronic Q fever |
| Q36761305 | Host innate immune response to Mycobacterium tuberculosis |
| Q38518485 | Host susceptibility to non-tuberculous mycobacterial infections |
| Q45006012 | Host-Directed Therapeutic Strategies for Tuberculosis |
| Q92632477 | Host-Directed Therapy as a Novel Treatment Strategy to Overcome Tuberculosis: Targeting Immune Modulation |
| Q36653997 | Host-directed therapy targeting the Mycobacterium tuberculosis granuloma: a review |
| Q36673887 | IL-10 inhibits mature fibrotic granuloma formation during Mycobacterium tuberculosis infection |
| Q36754320 | IL-1β promotes antimicrobial immunity in macrophages by regulating TNFR signaling and caspase-3 activation |
| Q30410330 | IL-21 promotes late activator APC-mediated T follicular helper cell differentiation in experimental pulmonary virus infection |
| Q34747287 | IL-6 mediates 11βHSD type 2 to effect progression of the mycobacterial cord factor trehalose 6,6'-dimycolate-induced granulomatous response |
| Q38287572 | Immune reconstitution inflammatory syndrome associated with biologic therapy |
| Q38265850 | Immunity and Immunopathology in the Tuberculous Granuloma |
| Q35116998 | Immunology studies in non-human primate models of tuberculosis |
| Q47095521 | Impact of TNF -308 G>A (rs1800629) gene polymorphism in modulation of leprosy risk: a reappraise meta-analysis of 14 case-control studies. |
| Q64272970 | Increased Risk of Herpes Zoster in Young and Metabolically Healthy Patients with Inflammatory Bowel Disease: A Nationwide Population-Based Study |
| Q88599082 | Inflammatory and Anti-inflammatory Responses Co-exist Inside Lung Granuloma of Fatal Cases of Coccidioidomycosis: A Pilot Report |
| Q34394609 | Influence of HTLV-1 on the clinical, microbiologic and immunologic presentation of tuberculosis |
| Q36639141 | Is CXCL10/CXCR3 axis overexpression a better indicator of leprosy type 1 reaction than inducible nitric oxide synthase? |
| Q54192665 | Isoniazid-induced control of Mycobacterium tuberculosis by primary human cells requires interleukin-1 receptor and tumor necrosis factor. |
| Q37036695 | Lack of alpha-1 integrin alters lesion morphology during pulmonary Mycobacterium tuberculosis infection |
| Q34166235 | Lactoferrin modulation of mycobacterial cord factor trehalose 6-6'-dimycolate induced granulomatous response. |
| Q35199257 | Latent tuberculosis screening tests and active tuberculosis infection rates in Turkish inflammatory bowel disease patients under anti-tumor necrosis factor therapy |
| Q37164550 | Lymphotoxin-alpha and TNF have essential but independent roles in the evolution of the granulomatous response in experimental leprosy |
| Q39437874 | Lysosomal phospholipase A2: a novel player in host immunity to Mycobacterium tuberculosis |
| Q92502050 | M. tuberculosis infection and antigen specific cytokine response in healthcare workers frequently exposed to tuberculosis |
| Q37856707 | Macrophages and control of granulomatous inflammation in tuberculosis |
| Q41585430 | Mannose-capped Lipoarabinomannan from Mycobacterium tuberculosis induces soluble tumor necrosis factor receptor production through tumor necrosis factor alpha-converting enzyme activation |
| Q21136107 | Mathematical Modeling of Tuberculosis Bacillary Counts and Cellular Populations in the Organs of Infected Mice |
| Q50056000 | Measuring bovine γδ T cell function at the site of Mycobacterium bovis infection |
| Q35623280 | Microarray analysis of the in vitro granulomatous response to Mycobacterium tuberculosis H37Ra. |
| Q101051175 | Modelling early events in Mycobacterium bovis infection using a co-culture model of the bovine alveolus |
| Q37311539 | Multifunctional T Cell Response to DosR and Rpf Antigens Is Associated with Protection in Long-Term Mycobacterium tuberculosis-Infected Individuals in Colombia |
| Q30501800 | Multiscale computational modeling reveals a critical role for TNF-α receptor 1 dynamics in tuberculosis granuloma formation |
| Q37071295 | Mycobacterium marinum: a potential immunotherapy for Mycobacterium tuberculosis infection |
| Q35139260 | Mycobacterium tuberculosis culture filtrate protein 10-specific effector/memory CD4⁺ and CD8⁺ T cells in tubercular pleural fluid, with biased usage of T cell receptor Vβ chains |
| Q53553294 | Mycobacterium tuberculosis-induced cell death of primary human monocytes and macrophages is not significantly modulated by tumor necrosis factor-targeted biologicals. |
| Q34460946 | Natural transmission of Plasmodium berghei exacerbates chronic tuberculosis in an experimental co-infection model |
| Q33844604 | Novel murine model of chronic granulomatous lung inflammation elicited by carbon nanotubes |
| Q36580383 | One Episode of Self-Resolving Plasmodium yoelii Infection Transiently Exacerbates Chronic Mycobacterium tuberculosis Infection |
| Q35665434 | PPE38 modulates the innate immune response and is required for Mycobacterium marinum virulence |
| Q35582660 | Paracoccidioides brasiliensis interferes on dendritic cells maturation by inhibiting PGE2 production |
| Q28750276 | Potential role for IL-2 ELISpot in differentiating recent and remote infection in tuberculosis contact tracing |
| Q52918534 | Proposed management of childhood tuberculosis in low-incidence countries. |
| Q38267397 | Pulmonary Mycobacterium kansasii Infection Mimicking Malignancy on the (18)F-FDG PET Scan in a Patient Receiving Etanercept: A Case Report and Literature Review. |
| Q40517811 | Re-initiation of biologics after the development of tuberculosis under anti-TNF therapy. |
| Q34087566 | Reactivation of M. tuberculosis infection in trans-membrane tumour necrosis factor mice |
| Q39301083 | Reduction of chemokine secretion in response to mycobacteria in infliximab-treated patients |
| Q44617630 | Resistance to mycobacterial infection: a pattern of early immune responses leads to a better control of pulmonary infection in C57BL/6 compared with BALB/c mice. |
| Q38003929 | Revisiting the role of the granuloma in tuberculosis |
| Q36639862 | Risk and prevention of tuberculosis and other serious opportunistic infections associated with the inhibition of tumor necrosis factor |
| Q43994517 | Risk of infection during treatment with tumor necrosis factor-alpha inhibitors |
| Q40554011 | Risk of tuberculosis during infliximab therapy for inflammatory bowel disease, rheumatoid arthritis, and spondyloarthropathy: A meta-analysis |
| Q40382190 | Role and contribution of pulmonary CD103+ dendritic cells in the adaptive immune response to Mycobacterium tuberculosis |
| Q36853424 | Role of the chemokine decoy receptor D6 in balancing inflammation, immune activation, and antimicrobial resistance in Mycobacterium tuberculosis infection |
| Q36995803 | Screening for tuberculosis infection prior to initiation of anti-TNF therapy |
| Q35638259 | Serious infections with antirheumatic therapy: are biologicals worse? |
| Q79780542 | Serum interleukin-18 and soluble tumour necrosis factor receptor 2 are associated with disease severity in patients with paracoccidioidomycosis |
| Q36298451 | Structural determination and Toll-like receptor 2-dependent proinflammatory activity of dimycolyl-diarabino-glycerol from Mycobacterium marinum |
| Q33635087 | Substance P signaling contributes to granuloma formation in Taenia crassiceps infection, a murine model of cysticercosis |
| Q38589372 | Synergy between individual TNF-dependent functions determines granuloma performance for controlling Mycobacterium tuberculosis infection. |
| Q35164131 | T lymphocyte surface expression of exhaustion markers as biomarkers of the efficacy of chemotherapy for tuberculosis |
| Q54220688 | The increased protection and pathology in Mycobacterium tuberculosis-infected IL-27R-alpha-deficient mice is supported by IL-17A and is associated with the IL-17A-induced expansion of multifunctional T cells. |
| Q37652470 | The role of dendritic cells in mycobacterium-induced granulomas |
| Q34985202 | The roles of microRNAs on tuberculosis infection: meaning or myth? |
| Q37855144 | The secret trumps, impelling the pathogenicity of tubercle bacilli |
| Q33315753 | Tumor necrosis factor blockade in chronic murine tuberculosis enhances granulomatous inflammation and disorganizes granulomas in the lungs |
| Q36806922 | Tumor necrosis factor inhibitors and infection complications |
| Q30502462 | Tumor necrosis factor signaling mediates resistance to mycobacteria by inhibiting bacterial growth and macrophage death |
| Q35851626 | Understanding latent tuberculosis: a moving target |
| Q57458673 | Upregulation of miR-196b-5p attenuates BCG uptake via targeting SOCS3 and activating STAT3 in macrophages from patients with long-term cigarette smoking-related active pulmonary tuberculosis |
| Q40462535 | Vanin-1 controls granuloma formation and macrophage polarization in Coxiella burnetii infection. |
| Q27321593 | Variability in tuberculosis granuloma T cell responses exists, but a balance of pro- and anti-inflammatory cytokines is associated with sterilization |
| Q36679224 | Who puts the tubercle in tuberculosis? |
| Q38082741 | Within the Enemy's Camp: contribution of the granuloma to the dissemination, persistence and transmission of Mycobacterium tuberculosis |
| Q82719630 | [Infectious complications of biologic therapy in patients with rheumatoid arthritis] |